Invasiveness in vitro and biological markers in human primary glioblastomas

[1]  M. Brada.  Pathology and Genetics of Tumours of the Nervous System , 2001, British Journal of Cancer.

[2]  P. Kleihues,et al.  Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors , 2000, Toxicologic pathology.

[3]  M. Kornfeld.  Russell and Rubinstein's pathology of tumors of the nervous system, sixth edition , 1999 .

[4]  H. Kashiwazaki,et al.  Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme. , 1999, Cancer research.

[5]  V. P. Collins,et al.  Progression as exemplified by human astrocytic tumors. , 1999, Seminars in cancer biology.

[6]  A. C. Johannessen,et al.  Mutations of the p53 gene in oral squamous‐cell carcinomas from sudanese dippers of nitrosamine‐rich toombak and non‐snuff‐dippers from the Sudan and Scandinavia , 1999, International journal of cancer.

[7]  G. Sauter,et al.  Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen‐metabolising enzymes , 1998, International journal of cancer.

[8]  T. Sugai,et al.  Correlation of Histologic Morphology and Tumor Stage With Molecular Genetic Analysis Using Microdissection in Gastric Carcinomas , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[9]  E. D. de Vries,et al.  Mutual interactions between p53 and growth factors in cancer. , 1998, Anticancer research.

[10]  E. Seftor,et al.  Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. , 1998, The American journal of pathology.

[11]  L. Qin,et al.  Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness. , 1998, Chinese medical journal.

[12]  D. Louis,et al.  Histopathologic and immunohistochemical prognostic factors in malignant gliomas. , 1997, Current opinion in oncology.

[13]  Y. Yonekawa,et al.  Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. , 1996, Brain pathology.

[14]  B. Zoll,et al.  Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis , 1995, Journal of Neurology.

[15]  D. Ellison,et al.  Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[16]  A. Kaye,et al.  Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma. , 1995, Neurosurgery.

[17]  S. Leenstra,et al.  Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. , 1994, British Journal of Cancer.

[18]  R. Bjerkvig,et al.  Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF‐α, bFGF, IL‐2] on glioma spheroid growth, migration and invasion , 1994, International journal of cancer.

[19]  P. Kleihues,et al.  Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K‐ras gene , 1992, Cancer.

[20]  R. Bjerkvig,et al.  Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro , 1990, Acta Neuropathologica.

[21]  O D Laerum,et al.  Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. , 1990, Cancer research.

[22]  R. Bjerkvig,et al.  Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. , 1986, Cancer research.

[23]  R. Bjerkvig,et al.  Interaction between rat glioma cells and normal rat brain tissue in organ culture. , 1985, Journal of the National Cancer Institute.

[24]  L. de Ridder,et al.  Invasion of rat neurogenic cell lines in embryonic chick heart fragments in vitro. , 1981, Journal of the National Cancer Institute.

[25]  Dorothy S. Russell,et al.  Pathology of Tumours of the Nervous System , 1960 .

[26]  P. Kleihues,et al.  Genetic alterations associated with the evolution and progression of astrocytic brain tumours , 2004, Virchows Archiv.

[27]  C. Fenoglio-Preiser,et al.  p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[28]  R. McLendon,et al.  Russell and Rubinstein's pathology of tumors of the nervous system , 1998 .

[29]  T. Mikkelsen.  Brain tumor invasion : biological, clinical, and therapeutic considerations , 1998 .

[30]  L. P. Paul,et al.  Inhibition of Epidermal Growth Factor Receptor-associated Tyrosine Kinase Blocks Glioblastoma Invasion of the Brain. , 1997, Neurosurgery.

[31]  A. Bhushan,et al.  Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain. , 1997, Neurosurgery.

[32]  T. Mikkelsen,et al.  Glioma cell invasion visualized by scanning confocal laser microscopy in an in vitro co-culture system. , 1995, Invasion & metastasis.